| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 08/13/2009 | US20090203110 COMPOSITION EXHIBITING A VON WILLEBRAND FACTOR (vWF) PROTEASE ACTIVITY COMPRISING A POLYPEPTIDE CHAIN WITH THE AMINO ACID SEQUENCE AAGGILHLELLV |
| 08/13/2009 | US20090203078 Process for producing polypeptide |
| 08/13/2009 | US20090203046 Methods for identifying purkinje cells using the corl2 gene as a target |
| 08/13/2009 | US20090203044 Sphingosine-1-phosphate lyase polypeptides, polynucleotides and modulating agents and methods of use therefor |
| 08/13/2009 | US20090203043 Protein phosphorylation by basophilic serine/threonine kinases in insulin signaling pathways |
| 08/13/2009 | US20090203041 Bmp4 inhibitors |
| 08/13/2009 | US20090203040 Detection of specific nitrated markers |
| 08/13/2009 | US20090203039 Monoclonal antibody to soluble lox-1 |
| 08/13/2009 | US20090203038 Negative Mimic Antibody For Use as a Blocking Reagent In BNP Immunoassays |
| 08/13/2009 | US20090203037 Anti-T. Cruzi Antibodies and Methods of Use |
| 08/13/2009 | US20090203036 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 08/13/2009 | US20090203034 Reagents for the detection of tyrosine phosphorylation in brain ischemia signaling pathways |
| 08/13/2009 | US20090202991 biomarkers, immunohistochemistry, non-invasive, for determining the state of a particular disease in the human body; for prognosis, prediction, screening, early diagnosis, staging, therapy selection and treatment monitoring of a marker-detectable disease such as cancer |
| 08/13/2009 | US20090202986 Methods of optimizing antibody variable region binding affinity |
| 08/13/2009 | US20090202980 Cross-Beta Structure Comprising Amyloid Binding Proteins and Methods for Detection of the Cross-Beta Structure, for Modulating Cross-Beta Structures Fibril Formation and for Modulating Cross-Beta Structure-Mediated Toxicity and Method for Interfering With Blood Coagulation |
| 08/13/2009 | US20090202979 Production of antibody formats and immunological applications of said formats |
| 08/13/2009 | US20090202627 Methods and compositions for diseases associated with amyloidosis |
| 08/13/2009 | US20090202595 Anti-pdef antibodies and uses thereof |
| 08/13/2009 | US20090202594 Anti-bacterial Vaccine Compositions |
| 08/13/2009 | US20090202585 Tat-based tolerogen compositions and methods for making and using same |
| 08/13/2009 | US20090202580 Method for the preparation of specific antibodies against saccharidic antigens |
| 08/13/2009 | US20090202578 Surface proteins from coagulase-negative staphylococci and staphylococcus aureus that generate cross-reactive monoclonal and polyclonal antibodies |
| 08/13/2009 | US20090202577 CASB618 Polynucleotides and Polypeptides and Their Use |
| 08/13/2009 | US20090202573 Polymeric conjugates containing positively-charged moieties |
| 08/13/2009 | US20090202572 Compositions and methods for modulating bone mass |
| 08/13/2009 | US20090202569 Prophylactic/Therapeutic Agent for Cancer |
| 08/13/2009 | US20090202568 Binding members for interleukin-4 receptor alpha (IL-4Ra)-173 |
| 08/13/2009 | US20090202564 Methods of isolating stem cells |
| 08/13/2009 | US20090202562 Anti-gfralpha3 antibodies |
| 08/13/2009 | US20090202561 Novel raag10 cell surface target and a family of antibodies recognizing that target |
| 08/13/2009 | US20090202559 conjugated drug for drug targeting at pancreatic cancer cell; biodrugs as antitumor agent, anticarcinogenic agent; free of side effect |
| 08/13/2009 | US20090202557 Compositions and methods for crystallizing antibody fragments |
| 08/13/2009 | US20090202556 Anti-claudin-4 antibody |
| 08/13/2009 | US20090202555 Antibodies against a peptide epitope of apoliporotein b |
| 08/13/2009 | US20090202554 Method of modulation of interaction between receptor and ligand |
| 08/13/2009 | US20090202553 Antibodies against anthrax protective antigen |
| 08/13/2009 | US20090202552 Gene expressed in prostate cancer and methods of use |
| 08/13/2009 | US20090202549 Anti-IL-12 Antibodies, Epitopes, Compositions, Methods and Uses |
| 08/13/2009 | US20090202547 Antibodies that block receptor protein tyrosine kinase activation, methods of screening for and uses thereof |
| 08/13/2009 | US20090202546 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof |
| 08/13/2009 | US20090202539 METHOD FOR TREATING CANCER USING ANTI-WNT2 MONOCLONAL ANTIBODIES AND siRNA |
| 08/13/2009 | US20090202538 F11 receptor (f11r) antagonists as therapeutic agents |
| 08/13/2009 | US20090202537 FcGammaRIIB Specific Antibodies and Methods of Use Thereof |
| 08/13/2009 | US20090202536 Antibody-drug conjugates and methods |
| 08/13/2009 | US20090202535 Method for neutralizing effects of sPLA2 |
| 08/13/2009 | US20090202534 Compositions and methods for modulating immune responses |
| 08/13/2009 | US20090202532 High Functional Bispecific Antibody |
| 08/13/2009 | US20090202530 Identification of Tumor-Associated Antigens for Diagnosis and Therapy |
| 08/13/2009 | US20090202528 Surface-Located Streptococcus Pneumoniae Polypeptides |
| 08/13/2009 | US20090202526 Agonist anti-trkc antibodies and methods using same |
| 08/13/2009 | US20090202523 Antibodies against a peptide epitope of apoliporotein b |
| 08/13/2009 | US20090202522 Use of goat serum for veterinary treatment |
| 08/13/2009 | US20090202504 Methods for the detection and prognosis of breast tumors |
| 08/13/2009 | US20090202469 Detection of inflammatory disease and composition for preventing or treatment of inflammatory disease |
| 08/13/2009 | US20090202438 Epitope regions of a thyrotrophin (tsh) receptor, uses thereof and antibodies thereto |
| 08/13/2009 | US20090202437 Therapeutic Use of Lpi, a Staphylococcal Lectin Pathway Inhibitor in Inflammatory diseases |
| 08/13/2009 | US20090202432 Treatment and prophylaxis of amyloidosis |
| 08/13/2009 | US20090202039 Methods for Sterilizing Biological Materials Containing Non-Aqueous Solvents |
| 08/13/2009 | CA2715127A1 Siva3, its preparation and use |
| 08/13/2009 | CA2714413A1 Antibody capable of binding specifically to ab-oligomer, and use thereof |
| 08/13/2009 | CA2714071A1 Alpha 5 - beta 1 antibodies and their uses |
| 08/13/2009 | CA2713935A1 Engineered anti-tslpr antibodies |
| 08/13/2009 | CA2713933A1 Camptothecin-binding moiety conjugates |
| 08/13/2009 | CA2713786A1 Anti trka antibodies and derivatives thereof |
| 08/13/2009 | CA2713504A1 Anti-cd79b antibodies and immunoconjugates and methods of use |
| 08/13/2009 | CA2713281A1 Engineered antibody constant domain molecules |
| 08/13/2009 | CA2712965A1 Antigen-binding polypeptides against cartilage degeneration |
| 08/13/2009 | CA2712518A1 Compositions and methods for the treatment of tumor of hematopoietic origin |
| 08/13/2009 | CA2711798A1 Composition comprising antibody that binds to domain ii of her2 and acidic variants thereof |
| 08/13/2009 | CA2711794A1 1d05 pcsk9 antagonists |
| 08/13/2009 | CA2711791A1 1b20 pcsk9 antagonists |
| 08/12/2009 | EP2088431A1 METHOD FOR ANALYSIS OF HEPATITIS B VIRUS s ANTIGEN |
| 08/12/2009 | EP2088159A1 Antibody recognizing c-domain of midkine |
| 08/12/2009 | EP2088158A2 Monoclonal antibody against the CCR5 chemokine receptor |
| 08/12/2009 | EP2087908A1 Antibodies to opgl |
| 08/12/2009 | EP2087907A2 Method and system to remove cytokine inhibitor in patients |
| 08/12/2009 | EP2087904A1 Therapeutic use of peptides derived from Bcl-XL protein in cancer patients |
| 08/12/2009 | EP2087789A1 Fto-modified non-human mammal |
| 08/12/2009 | EP2087103A1 Cancerous disease modifying antibodies |
| 08/12/2009 | EP2087008A1 TREATMENT AND PREVENTION OF CHRONIC ASTHMA USING ANTAGONISTS OF INTEGRIN alphaVbeta6 |
| 08/12/2009 | EP2087007A2 Agonist trkb antibodies and uses thereof |
| 08/12/2009 | EP2087006A2 Anti-notch3 agonist antibodies and their use in the treatment of notch3-related diseases |
| 08/12/2009 | EP2087005A2 Compounds |
| 08/12/2009 | EP2087004A2 A novel passive vaccine for candida infections |
| 08/12/2009 | EP2087003A2 Antibody with protein a selectivity |
| 08/12/2009 | EP2087002A2 Compositions and methods for binding sphingosine-1-phosphate |
| 08/12/2009 | EP2086996A1 Marker specific to an oxidation degradation of tissues containing type iii collagen, means and methods, and kits for the tracking diagnosis or prognosis of pathologies targeted by said marker |
| 08/12/2009 | EP2086584A2 Antibodies that bind cxcr7 epitopes |
| 08/12/2009 | EP2086534A1 Compounds, compositions and methods for controlling invertebrate pests |
| 08/12/2009 | EP1814489A4 Therapeutic implant |
| 08/12/2009 | EP1675579B1 Human epo mimetic hinge core mimetibodies, compositions, methods and uses |
| 08/12/2009 | EP1576011B1 Inhibition of il-17 production |
| 08/12/2009 | EP1456223B1 Rapidly maturing fluorescent proteins and methods for using the same |
| 08/12/2009 | EP1385882B9 Peptides and related molecules that bind to tall-1 |
| 08/12/2009 | EP1255780B1 Methods for generating human monoclonal antibodies |
| 08/12/2009 | EP1149111B1 Method and composition for angiogenesis inhibition |
| 08/12/2009 | EP1137941B1 Protein scaffolds for antibody mimics and other binding proteins |
| 08/12/2009 | CN101506239A Antihuman alpha9 integrin antibody and use of the same |
| 08/12/2009 | CN101506238A Methods and compositions with enhanced therapeutic activity |
| 08/12/2009 | CN101506237A Anti-C5aR antibodies with improved properties |